Jump to main content
Jump to site search


Hyaluronic acid cloaked oleic acid nanoparticle inhibits MAPK signaling with sub-cellular DNA damage in colon cancer

Abstract

RAS-RAF-MEK-ERK cascade in mitogen activated protein kinase (MAPK) signaling has been highjacked in colon cancer. However, selective targeting of MAPK signaling components in colon cancer cells remained a surmountable challenge. To address these, we have engineered hyaluronic acid cloaked 154 nm diameter oleic acid nanoparticles (HA-OA-NPs) comprising ERK inhibitor (AZD6244) and DNA damaging drug (cisplatin) simultaneously. Dual drugs were slowly released from the HA-OA-NPs at acidic pH (pH = 5.5) over 72 h. HCT-116 colon cancer cells engulfed these HA-OA-NPs by CD44 receptor and clathrin dependent endocytosis pathways followed by accumulating into lysosomes over 6 h. These HA-OA-NPs inhibited phosphorylation of extracellular signal-regulated kinases (ERK1 and ERK2) and damaged sub-cellular DNA to induce remarkable colon cancer cell (HCT-116 and DLD-1) death in contrast to free drug cocktail at 24 h post incubation. Due to the biocompatibility and biodegradability of the nanoparticle components, HA-OA-NPs could be translated into clinics as platform for synchronized inhibition of multiple targets for improved therapeutic efficacy in colon cancer patients.

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 09 Mar 2017, accepted on 31 Mar 2017 and first published on 31 Mar 2017


Article type: Paper
DOI: 10.1039/C7TB00656J
Citation: J. Mater. Chem. B, 2017, Accepted Manuscript
  •   Request permissions

    Hyaluronic acid cloaked oleic acid nanoparticle inhibits MAPK signaling with sub-cellular DNA damage in colon cancer

    S. Palvai, M. M. Kuman and S. Basu, J. Mater. Chem. B, 2017, Accepted Manuscript , DOI: 10.1039/C7TB00656J

Search articles by author